Drugs / rhBMP-12
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00936559 | Sep 2010 → Feb 2012 | rotator cuff syndrome | Pfizer | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rhBMP-12 | “PURPOSE: To assess functional recovery and structural outcomes in detail after implanting recombinant human bone morphogenetic protein-12 (rhBMP-12)/absorbable collagen sponge...” PMID 28932752 ↗ Sep 2017 |
| Modality | Protein / enzyme biologic | “recombinant human bone morphogenetic protein-12 (rhBMP-12)” PMID 28932752 ↗ Sep 2017 |